Zlatanic J, Waye J D, Kim P S, Baiocco P J, Gleim G W
Section of Gastroenterology, Department of Medicine, Lenox Hill Hospital, New York, New York, USA.
Gastrointest Endosc. 1999 Jun;49(6):731-5. doi: 10.1016/s0016-5107(99)70291-9.
Residual adenoma is frequently found at the site of endoscopically resected large sessile adenomas on follow-up examination. We evaluated the efficacy of a thermal energy source, the argon plasma coagulator, to destroy visible residual adenoma after piecemeal resection of sessile polyps.
Seventy-seven piecemeal polypectomies with or without the use of argon plasma coagulator were analyzed retrospectively. All polyps were sessile, 20 mm or greater in size. The results from three groups of patients were compared. The study group was composed of patients who had visible residual adenoma after piecemeal polypectomy and had the base of the polypectomy site treated with the argon plasma coagulator. The first comparison group consisted of patients who underwent standard piecemeal polypectomy in whom the colonoscopist thought that all adenomatous tissue was removed and no further treatment was necessary. The second comparison group included patients in whom visible residual adenoma was left at the base after piecemeal resection of large adenomas. Follow-up colonoscopy was performed approximately 6 months after the initial procedure to check for recurrent/residual adenomatous tissue.
The argon plasma coagulator was used after 30 piecemeal polypectomies in an attempt to eradicate visible residual adenomatous tissue; at follow-up, 50% of these cases had complete eradication of adenoma. The group in whom all visible tumor was removed by piecemeal polypectomy alone had an adenoma eradication rate of 54% on follow-up colonoscopy. In the patients in whom visible residual adenoma was left at the site the recurrence rate was 100% on the follow-up examination. Bleeding necessitating endoscopic therapy occurred once (3.3%) in the argon plasma coagulator group; there were four (12.5%) bleeding episodes and one (3.1%) confined retroperitoneal perforation in the complete piecemeal polypectomy group and no complications in the group in which polypectomy was incomplete.
Argon plasma coagulator ablation of residual adenomatous tissue at the polypectomy base is safe and useful. It helps to complete the eradication of large sessile polyps when there is visible evidence of residual polyp.
在随访检查中,经常在内镜切除的大型无蒂腺瘤部位发现残留腺瘤。我们评估了一种热能源——氩等离子体凝固器,在无蒂息肉分片切除后破坏可见残留腺瘤的疗效。
回顾性分析了77例使用或未使用氩等离子体凝固器的分片息肉切除术。所有息肉均为无蒂,大小在20毫米或更大。比较了三组患者的结果。研究组由分片息肉切除术后有可见残留腺瘤且息肉切除部位基底用氩等离子体凝固器治疗的患者组成。第一个比较组由接受标准分片息肉切除术的患者组成,结肠镜检查医生认为所有腺瘤组织均已切除且无需进一步治疗。第二个比较组包括在大型腺瘤分片切除后基底留有可见残留腺瘤的患者。在初始手术后约6个月进行随访结肠镜检查,以检查复发性/残留腺瘤组织。
30例分片息肉切除术后使用氩等离子体凝固器试图根除可见残留腺瘤组织;随访时,这些病例中有50%的腺瘤被完全根除。仅通过分片息肉切除术切除所有可见肿瘤的组在随访结肠镜检查中的腺瘤根除率为54%。在残留部位留有可见残留腺瘤的患者中,随访检查时复发率为100%。氩等离子体凝固器组发生一次需要内镜治疗的出血(3.3%);完全分片息肉切除术组有四次出血事件(12.5%)和一次局限性腹膜后穿孔(3.1%),而息肉切除术不完全的组无并发症发生。
氩等离子体凝固器对息肉切除基底的残留腺瘤组织进行消融是安全有效的。当有可见残留息肉证据时,它有助于完成大型无蒂息肉的根除。